HEALTH CATALYST INC's ticker is HCAT and the CUSIP is 42225T107. A total of 155 filers reported holding HEALTH CATALYST INC in Q2 2023. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $849,000 | -29.1% | 83,845 | -12.5% | 0.00% | -20.0% |
| Q2 2023 | $1,198,000 | -1.1% | 95,845 | -7.6% | 0.01% | 0.0% |
| Q1 2023 | $1,211,000 | +9.8% | 103,745 | 0.0% | 0.01% | 0.0% |
| Q4 2022 | $1,103,000 | +82.6% | 103,745 | +66.5% | 0.01% | +66.7% |
| Q3 2022 | $604,000 | – | 62,319 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Daventry Group, LP | 852,504 | $8,269,000 | 11.18% |
| Nepsis Inc. | 826,841 | $8,020,000 | 2.90% |
| First Light Asset Management, LLC | 1,149,833 | $11,153,000 | 1.13% |
| Bullseye Asset Management LLC | 55,434 | $538,000 | 0.31% |
| Portolan Capital Management | 303,602 | $2,945,000 | 0.31% |
| CVS HEALTH Corp | 32,273 | $313,000 | 0.30% |
| Rock Springs Capital Management LP | 880,000 | $8,536,000 | 0.22% |
| Granahan Investment Management | 648,299 | $6,289,000 | 0.20% |
| Bares Capital Management | 452,400 | $4,388,000 | 0.17% |
| Rhenman & Partners Asset Management AB | 180,000 | $1,588,000 | 0.17% |